Home
Novartis

Novartis Market Share Analysis for March 2026

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.

Health > Biotechnology and Pharmaceuticals

Domainnovartis.com.au

Year Founded1996

Employees> 10001

Annual Revenue> $1B

Novartis

Novartis (including company regionals)

novartis.com.au

See more website traffic and engagement information

Novartis Revenue up to March 2026 is > 1B

revenue generated by Novartis top domains

Novartis top domains revenue over 3 years

Revenue for Novartis top domains

novartis.com.au> 1B

See more with Sales Intelligence

Novartis Stock price in March 2026

Novartis stock is traded under the ticker #NVS. Below you can review Novartis stock performance in the past 12 months up to March 2026

Total visits to Novartis's top domains

Understand Novartis market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

novartis.com.au--

See more with Sales Intelligence

Avg. visit duration in Novartis's top domains

Analyze Novartis engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Novartis's top domains

See how Novartis keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

novartis.com.au--

See more with Sales Intelligence

Novartis top competitors by domain

Top similar sites in March 2026, ranked by their affinity

pfizer.com.auCompany NamePfizerEmployees> 10001HQUnited States, New York, New York CityAnnual revenue> $1BTotal visits11.4KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Novartis

These are the website technologies, by industry, used by Novartis top domains

Advertising (9)

DoubleClick

Social (5)

Instagram

Conversion & Analytics (4)

Google Analytics

Audio Video Media (3)

YouTube

More Technologies

8

See all

News & Signals from Novartis

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNovartis AG acquired Gyroscopetx on Dec 1st '21.In December 2021, Novartis announced the acquisition of Gyroscope Therapeutics, the UK-based company behind an investigational gene therapy for geographic atrophy that is the focus of key clinical trials in Australia.

NewsNovartis AG is developing gallium based radioligand imaging molecules and lutetium therapy molecules.Similarly, Novartis (AAA) is working on gallium (Ga-68) based radioligand imaging molecules and lutetium (Lu-177) therapy molecules aimed at the treatment of prostate cancer.

NewsMesoblast Limited partnered with Novartis AG on Nov 20th '20.Mesoblast entered into a license and collaboration agreement with Novartis on November 20, 2020 for the development, manufacture and commercialization of remestemcel-L, with an initial focus on the treatment of ARDS, including that associated with COVID-19, and other indications.